Navigation Links
Otonomy Files Registration Statement for Proposed Initial Public Offering
Date:7/14/2014

SAN DIEGO, July 14, 2014 /PRNewswire/ -- Otonomy, Inc., a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases and disorders of the inner and middle ear, today announced that it has publicly filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (SEC) relating to a proposed initial public offering of shares of its common stock. All shares of common stock to be sold in the offering will be offered by Otonomy. The number of shares to be offered and the price range for the proposed offering have not yet been determined.

J.P. Morgan Securities LLC and BofA Merrill Lynch are acting as joint book-running managers for the offering, and Piper Jaffray & Co. and Sanford C. Bernstein & Co., LLC are acting as co-managers for the offering.

A registration statement relating to these securities has been filed with the SEC, but has not yet become effective. These securities may not be sold, nor may offers to buy be accepted, prior to the time the registration statement becomes effective. This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

The offering will be made only by means of a prospectus. When available, copies of the preliminary prospectus may be obtained from J.P. Morgan Securities LLC, Attention: Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, or by telephone at (866) 803-9204; or BofA Merrill Lynch, 222 Broadway, New York, NY 10038, Attention: Prospectus Department, o
'/>"/>

SOURCE Otonomy, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Otonomy Doses First Subjects in Phase 3 Clinical Trials of OTO-201 in Pediatric Patients Undergoing Ear Tube Placement Surgery
2. Otonomy Enrolls First Patient in Pivotal Phase 2b Study of OTO-104 in Menieres Disease
3. Otonomy Acquires Assets and Patent Rights for Tinnitus Program
4. Otonomy Completes $45.9 Million Series C Equity Financing
5. MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics
6. EntreMed Files New Drug Global Clinical Trial Application For ENMD-2076 With China CFDA
7. Flexion Therapeutics Files Registration Statement for Proposed Initial Public Offering
8. Ormco Corporation Files Appeal to the Federal Court Against Ortho Classic H4 Bracket Patent Infringement
9. Molecular Profiles Joins Leading Consortium To Drive Paediatric Formulation Development
10. Family Talk Files Lawsuit Challenging Obamas Abortion Pill Mandate
11. Polaris Group Files New IND for ADI-PEG 20 in Leukemia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... SILVER SPRING, Md. , Aug. 29, 2014 /PRNewswire/ ... today that the U.S. District Court for the District ... in its favor in the company,s case against Sandoz, ... opinion, Judge Peter Sheridan ruled that U.S. ... Sandoz, Inc., and enjoined Sandoz from marketing its generic ...
(Date:8/29/2014)... 2014 /PRNewswire-iReach/ -- ChemImage will present a workshop focused ... Zealand Forensic Science Society,s 22 nd International ... Adelaide, Australia .  Forensic Scientists will be ... hyperspectral imaging can bring to examination procedures. ... of Product Development at ChemImage, will host a ...
(Date:8/29/2014)... and MENLO PARK, Calif. , Aug. ... (OTCQB: DMPI) ("DelMar" "the Company") today announced the ... The Company recently changed its fiscal year end to ... list its common stock on a national securities exchange ... statements as filed with the United States Securities Exchange ...
Breaking Medicine Technology:District Court Decision Received In Remodulin Patent Case 2ChemImage to Discuss Hyperspectral Imaging for Forensic Investigation at the ANZFSS 22nd International Symposium on the Forensic Sciences 2ChemImage to Discuss Hyperspectral Imaging for Forensic Investigation at the ANZFSS 22nd International Symposium on the Forensic Sciences 3DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 2DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 3DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 4DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 5
... 2011 Eli Lilly and Company (NYSE: ... signed agreements with private investors Care Capital and ... and privately-held biotechnology company. BioCritica, based in Central ... development and commercialization of Xigris® (drotrecogin alfa (activated)), ...
... ATLANTA, May 23, 2011 CardioMEMS, Inc ., ... is commercializing a proprietary wireless sensing and communication technology ... and CEO, Jay Yadav, M.D., was presented with a ... by the Atlanta Business Chronicle.  The award was conferred ...
Cached Medicine Technology:Lilly and Investor Group Form New Critical Care Company BioCritica, Sign Xigris License Agreement 2Lilly and Investor Group Form New Critical Care Company BioCritica, Sign Xigris License Agreement 3Lilly and Investor Group Form New Critical Care Company BioCritica, Sign Xigris License Agreement 4Lilly and Investor Group Form New Critical Care Company BioCritica, Sign Xigris License Agreement 5Lilly and Investor Group Form New Critical Care Company BioCritica, Sign Xigris License Agreement 6Lilly and Investor Group Form New Critical Care Company BioCritica, Sign Xigris License Agreement 7CardioMEMS Founder Dr. Jay Yadav Honored With Health-Care Heroes Award by the Atlanta Business Chronicle 2CardioMEMS Founder Dr. Jay Yadav Honored With Health-Care Heroes Award by the Atlanta Business Chronicle 3
(Date:8/29/2014)... Daily Gossip reveals in its Get Rid of Cold ... cold sores patient who suffered from this terrible health problem for ... to share her tips and advices, but also her experience with ... the Get Rid of Cold Sores Fast program says that she ... least 4 years outbreaks have become more frequent. , Ellie ...
(Date:8/29/2014)... (PRWEB) August 29, 2014 Cosmetic Town ... knowledge and authenticity of its doctors. Cosmetic Town ... the most renowned doctors in their field are chosen ... assure patients have a direct link to potentially hundreds ... doctors will be able to communicate through the site’s ...
(Date:8/29/2014)... FL (PRWEB) August 29, 2014 The ... anxiously awaited final rule (file code CMS–0052–P) today allowing ... using the 2011 Edition Certified EHR Technology (CEHRT) or ... Eligible Professionals (EPs) who have not been able to ... reporting period in 2014 can continue to use 2011 ...
(Date:8/29/2014)... August 29, 2014 Champion boxers Laila ... disease by appearing on the annual MDA Show of ... 31, 9/8c on ABC television stations across the country. ... current host of “All In, with Laila Ali," will ... Boy during the Muscular Dystrophy Association's nationally broadcast show. ...
(Date:8/29/2014)... August 29, 2014 As reported by WKMS.com ... Recovery , an Ohio municipal court drug has come up ... Fred Moses, who serves as the presiding judge in a ... makers to offer addicts a medicated treatment option that can ... the drug known as Vivitrol, which blocks receptors in the ...
Breaking Medicine News(10 mins):Health News:Get Rid of Cold Sores Fast Review Reveals Simple Way to Eliminate Cold Sores in 12 Hours 2Health News:Cosmetic Town Now Advocates for the Rights of Cosmetic Patients Using Novel Approach 2Health News:Quirk Healthcare Outlook on MU2 Delay Confirmation 2Health News:Champion Boxers Fight Back Against Muscle Disease 2Health News:Champion Boxers Fight Back Against Muscle Disease 3Health News:Ohio Judge Pushes for Addiction Recovery Tool 2Health News:Ohio Judge Pushes for Addiction Recovery Tool 3
... issue of Archives of Surgery,Individuals with diabetes appear to ... use more ventilator support and have more complications during ... 17 million Americans have diabetes, with one-third remaining undiagnosed, ... develop complications more frequently and do worse after an ...
... rare neurological disorder that causes hand movement without the person ... the action . ,The afflicted person may sometimes ... so, even to the point of having to use the ... new study identified the areas of the brain involved in ...
... of Archives of Surgery,the rate of cases of colitis ... more than doubled among patients hospitalized in the United ... more severe and associated with an increased mortality rate. ... percent to 3 percent of healthy adults and about ...
... from Saint Louis University School of Public Health has found ... ,Qiang John Fu, M.D., Ph.D conducted a study of twins ... also associated with conduct disorder, is why some people with ... to quit become depressed when they cant. ,Dr. ...
... more common in the United States between 1973 and 2002 ... Archives of Dermatology. The rates of the disease vary by ... occurs when certain cells of the lymph system (called T ... several types of lymphoma, according to background information in the ...
... or removal of the tonsils, none reported an ongoing ... . ,Together with the sense of smell ... taste contributes considerably to flavor perception during eating and ... enjoyment of foods and beverages, according to background information ...
Cached Medicine News:Health News:Diabetes may Lead to More Complications 2Health News:Alien Hand Syndrome Causes Random Hand Movement 2Health News:Colitis More Common in Hospitalized Patients 2Health News:Colitis More Common in Hospitalized Patients 3Health News:Colitis More Common in Hospitalized Patients 4Health News:Study Finds Genetic Link Between Smoking Addiction and Major Depression 2Health News:Cutaneous T-cell Lymphoma Shows Steady Increase 2Health News:Patients Undergoing Tonsillectomy Shows No Change of Taste 2
Our high quality therapeutic drug monitoring reagents, calibrators and controls are available for most chemistry analyzers. Reproducible and accurate results for your laboratory needs....
Revised Drug calibrator that replaces existing Drug calibrator - this product contains Lithium in addition to Digoxin, Phenobarbital, OPhenytoin, & Theophulline....
Liquichek Rheumatoid Factor Control is a liquid trilevel control designed to monitor rheumatoid factor testing procedures, including nephelometric and latex agglutination methods....
... BD Macro-Vue RPR (Rapid Plasma Reagin) ... Tests are nontreponemal testing procedures for ... in A Manual of Tests for ... manual are the most widely used ...
Medicine Products: